Public Procurement of Medicines in Europe: Key Findings and Best Practices 

Experts in the Pharmacoeconomics Department recently conducted a study on the best practices in the public procurement of medicines. Commissioned by the European Commission, this study aims to improve access to medicines, affordability, availability, and more. 

Public procurement of medicines can improve access, foster competition, and address important policy objectives. This study mapped and analyzed PPM practices across 32 European countries, revealing some fascinating insights. 

 Findings include:

• Different organizational forms of procurement, ranging from facility-based to centralized procurement.
• Use of various procedures and techniques, including the Most Economically Advantageous Tender
• Specific forms of procurement in the hospital sector
• Impacts on policy objectives, such as access to medicines and environmental protection
• Best practices for optimizing PPM in Europe

Discover the full report for a comprehensive understanding of PPM practices in Europe on the below link. Let’s work together to ensure affordable and accessible medicines for all!